Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs

Author(s): Graziella Anselmo Joanitti, Rayane Ganassin, Mosar Correa Rodrigues, Joao Paulo Figueiro Longo, Cheng-Shi Jiang, Jinsong Gu, Sandra Milena Leal Pinto, Maria de Fatima Menezes Almeida dos Santos, Ricardo Bentes de Azevedo, Luis Alexandre Muehlmann

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 17 , Issue 3 , 2017

Become EABM
Become Reviewer
Call for Editor


Nanotechnology has provided powerful tools to improve the chemotherapy of cancer. Different nanostructures have been developed which deliver the anticancer drugs more selectively to tumor than to healthy tissues. The result has generally been the increase in efficacy and safety of classical anticancer drugs. In recent years, several studies have focused not only on the delivery of anticancer drugs to tumors, but also on delivering the drugs to specific organelles of cancer cells. Endoplasmic reticulum, Golgi apparatus, lysosomes, mitochondria, and nucleus have been the targets of different nanostructured drug delivery systems developed with the goal of circumventing drugresistance, increasing drug efficacy, and so on. So far, the results described in the literature show that this strategy may be used to improve chemotherapy outcomes. In this review a discussion is presented on the strategies described in the literature to deliver anticancer drugs to specific organelles of cancer cells by using nanostructures.

Keywords: Anticancer therapy, chemotherapy, nanostructured drug delivery systems, nanotechnology, subcellular delivery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 08 January, 2017
Page: [224 - 236]
Pages: 13
DOI: 10.2174/1389557516666161013104554
Price: $65

Article Metrics

PDF: 35
PRC: 1